3-(Piperidin-1-yl)propyl-7-chloro-5,12-dioxo-5,12-dihydroindolizino[2,3-g]quinoline-6-carboxylate

ID: ALA4172174

PubChem CID: 145952029

Max Phase: Preclinical

Molecular Formula: C24H22ClN3O4

Molecular Weight: 451.91

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1c2cccnc2C(=O)c2c1c(C(=O)OCCCN1CCCCC1)c1c(Cl)cccn21

Standard InChI:  InChI=1S/C24H22ClN3O4/c25-16-8-5-13-28-20(16)18(24(31)32-14-6-12-27-10-2-1-3-11-27)17-21(28)23(30)19-15(22(17)29)7-4-9-26-19/h4-5,7-9,13H,1-3,6,10-12,14H2

Standard InChI Key:  SQYCBJPYLZNUDA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   12.1657  -20.4091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1645  -21.2286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8726  -21.6376    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.8708  -20.0002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5794  -20.4055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5828  -21.2307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2951  -21.6381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2884  -19.9877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0053  -20.3997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0070  -21.2225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7874  -20.1438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2724  -20.8085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7851  -21.4755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1173  -22.2269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9378  -22.3176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4252  -21.6506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0920  -20.8928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2988  -22.4553    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.2839  -19.1705    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1911  -19.4310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0083  -19.4242    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.7767  -18.7267    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.5731  -20.2323    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   17.4110  -18.7132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2282  -18.7064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6309  -17.9954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4481  -17.9886    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8595  -18.6930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6732  -18.6883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0797  -17.9790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6665  -17.2729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8467  -17.2760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5  8  1  0
  6  7  1  0
  7 10  1  0
  9  8  1  0
  9 10  2  0
 10 13  1  0
 12 11  2  0
 11  9  1  0
 12 13  1  0
 12 17  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
  7 18  2  0
  8 19  2  0
 11 20  1  0
 20 21  1  0
 20 22  2  0
 17 23  1  0
 21 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 32  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4172174

    ---

Associated Targets(Human)

HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Huh-7 (12904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Topoisomerase I (119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DNA (609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 451.91Molecular Weight (Monoisotopic): 451.1299AlogP: 3.80#Rotatable Bonds: 5
Polar Surface Area: 80.98Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.89CX LogP: 3.18CX LogD: 2.57
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.34Np Likeness Score: -0.84

References

1. Yu Q, Yang H, Zhu TW, Yu LM, Chen JW, Gu LQ, Huang ZS, An LK..  (2018)  Synthesis, cytotoxicity and structure-activity relationship of indolizinoquinolinedione derivatives as DNA topoisomerase IB catalytic inhibitors.,  152  [PMID:29705710] [10.1016/j.ejmech.2018.04.040]

Source